MoneyWorks4Me

Nutraplus India - Quaterly Results

05 Oct 2024 Evaluate
The revenue slipped marginally during the September 2021 quarter. A decline of about Rs. 0.44 millions was observed as compared to Rs. 0.00 millions during the corresponding quarter last year.The Total Profit for the quarter ended September 2021 of Rs. 0.92 millions grew from Rs.-13.90 millions Operating profit Margin for the quarter ended September 2021 improved to 0.92% as compared to -0.74% of corresponding quarter ended September 2020


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202109 202009 % Var 202109 202009 % Var 202103 202003 % Var
Sales 0.44 0.00 0.00 0.98 0.09 988.89 0.20 1066.68 -99.98
Other Income 0.49 0.00 0.00 6.07 0.30 1923.33 0.91 1.44 -36.81
PBIDT 0.92 -0.74 -224.32 6.78 -0.86 -888.37 -6.12 -356.93 -98.29
Interest 0.00 1.46 0.00 0.00 2.14 0.00 4.53 74.32 -93.90
PBDT 0.92 -2.20 -141.82 6.78 -3.00 -326.00 -245.16 -431.25 -43.15
Depreciation 0.00 11.70 0.00 0.00 23.68 0.00 0.00 47.01 0.00
PBT 0.92 -13.90 -106.62 6.78 -26.68 -125.41 -245.16 -478.26 -48.74
TAX 0.00 0.00 0.00 0.00 0.00 0.00 -8.52 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 -8.52 0.00 0.00
PAT 0.92 -13.90 -106.62 6.78 -26.68 -125.41 -236.64 -478.26 -50.52
Equity 170.46 170.46 0.00 170.46 170.46 0.00 170.46 170.46 0.00
PBIDTM(%) 209.09 0.00 0.00 691.84 -955.56 -172.40 -3060.00 -33.46 9044.76
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..